Phlebotomy for erythropoietin-associated malignant hypertension

Lancet. 1991 Jun 29;337(8757):1606. doi: 10.1016/0140-6736(91)93300-x.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Bloodletting*
  • Erythropoietin / adverse effects*
  • Humans
  • Hypertension, Malignant / chemically induced
  • Hypertension, Malignant / therapy*

Substances

  • Erythropoietin